Stock listing

NASDAQ:ORTX Orchard Therapeutics PLC Stock

Follow Orchard Therapeutics PLC into a list and get an email when it puts out news.

Last close · NASDAQ:ORTX

$16.70 USD

Close on Jan 25, 2024 · No longer trades

Mar 10, 2023 to last close +247.9% · daily closes, Mar 10, 2023 – Jan 25, 2024
Lowest – highest close
$4.58 – $16.70 USDSince Mar 10, 2023 · lowest Mar 17, 2023 · highest Jan 23, 2024

Delisted NASDAQ:ORTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ORTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Orchard Therapeutics PLC on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Aug 3, 2023
Decks
8 decks · latest Aug 3, 2023

Events

CallWhenStatus
Orchard Therapeutics (ORTX) Q2 2023 Earnings CallThu, Aug 03, 2023 · 8:00 AM ETReplay
Orchard Therapeutics (ORTX) Q1 2022 Earnings CallThu, May 12, 2022 · 8:00 AM ETReplay
Orchard Therapeutics (ORTX) Q4 2021 Earnings CallWed, Mar 30, 2022 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Q2 2023 Earnings PresentationEarnings19 slidesAug 3, 2023
Technical Presentation (May 2023)Technical41 slidesMay 23, 2023
Investor Presentation (January 2023)Investor deck27 slidesJan 9, 2023
Technical Presentation (December 2022)Technical40 slidesDec 12, 2022
40th Annual J.P. Morgan Healthcare Conference (January 2022)Conference25 slidesJan 10, 2022
2021 JP Morgan Healthcare ConferenceConference23 slidesJan 11, 2021
Conference Presentation (January 2020)Conference27 slidesJan 13, 2020
Conference Presentation (January 2019)Conference25 slidesJan 7, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past)
Director · Feb 9, 2021 – Feb 9, 2021 · Past
Charles A Rowland Jr
Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 2, 2021 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past)
Director · Jan 1, 2020 – Jan 24, 2024 · Past
Steven Altschuler
Other companies: Lexeo Therapeutics, Inc. (Chairman · Since at least Nov 2, 2023); 89bio Inc (Director · Since at least Mar 23, 2020); WW International, Inc. (Director · Since at least Sep 30, 2012); Covista Inc. (Director · May 8, 2018 – Nov 6, 2019 · Past); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Mead Johnson Nutrition CO (Director · Mar 10, 2009 – Jun 15, 2017 · Past)
Director · Feb 3, 2020 – Jan 24, 2024 · Past
Alicia Secor
Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past)
Director · Jan 1, 2020 – Jan 24, 2024 · Past
James Geraghty
Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Jul 17, 2019); Voyager Therapeutics, Inc. (Director · Since at least Jun 15, 2016); Palvella Therapeutics, Inc. (Director · May 22, 2017 – Dec 12, 2024 · Past); Juniper Pharmaceuticals Inc (Director · Aug 2, 2016 – Aug 14, 2018 · Past); Aceragen Inc. (Director · May 13, 2016 – Jun 23, 2022 · Past)
Director · Jan 1, 2020 – Jan 24, 2024 · Past
Frank E Thomas
Other companies: Spero Therapeutics, Inc. (Director · Since at least Nov 1, 2017); Larimar Therapeutics, Inc. (Director · Since at least Jun 30, 2016); AMAG Pharmaceuticals Inc (President & COO · Feb 23, 2017 – Feb 23, 2017 · Past)
See Remarks · Jan 1, 2020 – Jan 24, 2024 · Past
Joanne T Beck
Other companies: Astria Therapeutics Inc (Director · Since at least Feb 13, 2019)
Director · Jan 1, 2020 – Jan 24, 2024 · Past
Jon EllisDirector · Jan 1, 2020 – Jan 1, 2020 · Past
Marc DunoyerDirector · Jun 16, 2021 – Jan 24, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Orchard Therapeutics PLC.